Search results
2 new COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 15 hours agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
New 'FLiRT' COVID-19 Variants Are Responsible For 25% Of Infections
Women's Health via Yahoo News· 22 hours agoUnfortunately, a COVID-19 test won't tell you exactly which variant is responsible for your...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 3 days agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
What are the new COVID FLiRT variants, and are they in Wisconsin?
Gannett via AOL· 24 hours agoSymptoms may appear two to 14 days after exposure. Latest COVID guidance from the CDC In March 2024,...
OPKO Health Inc (OPK) Q1 2024 Earnings Call Transcript Highlights: Strategic Moves Amid ...
GuruFocus.com via Yahoo Finance· 1 day agoCost of Expenses: Decreased to $161.3 million in Q1 2024 from $172.4 million in Q1 2023. Pharmaceuticals Operating Loss: $27.7 million in Q1 2024 compared to... (NASDAQ:OPK ...
Opko Health (OPK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 days agoIn addition, we seek to bolster growth through the expansion of insurance coverage in our higher value specialty segments of oncology and urology, with...
The End of an Era? FDA Finalizes LDT Rule But Grandfathers Many Existing LDTs | JD Supra
JD Supra· 2 days agoOn May 6, 2024, the Food and Drug Administration (FDA) published its final rule for laboratory developed tests (LDTs). The final rule cemented the agency’s forecasted decision to increase the ...
...-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on...
FOX 59 Indianapolis· 7 days agoTarcocimab clinical and non-clinical data highlight strong 6-month efficacy profile in diabetic...
Covishield rolled back; should those jabbed with it need to worry? Experts answer
MSN News· 8 hours agoAfter AstraZeneca withdraws Covishield, should those who took the vaccine be worried about its...
Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
GuruFocus.com via Yahoo Finance· 6 days agoRevenue: Grew 7% year-over-year to $3.1 billion, excluding COVID antibodies contributions. Net Income: First quarter diluted net income per share was $9.55. Free Cash Flow: Generated $1.< ...